Screener
Candel Therapeutics, Inc. CADL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $358.91M.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
FAQ
- What is Candel Therapeutics, Inc.'s market capitalization?
- Candel Therapeutics, Inc. (CADL) reported market capitalization of $358.91M in Q1 2026.
- How has Candel Therapeutics, Inc.'s market capitalization changed year-over-year?
- Candel Therapeutics, Inc.'s market capitalization increased by 34.5% year-over-year, from $266.88M to $358.91M.
- What is the long-term trend for Candel Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s market capitalization has grown at a 8.4% compound annual growth rate (CAGR), from $224.36M to $310.18M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Candel Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude